AllianceBernstein Portfolio holdings
AllianceBernstein (AB), formed in 2000 through the merger of Alliance Capital and Bernstein, is a global asset management firm headquartered in Nashville, Tennessee, managing over $759 billion in assets as of late 2024 for institutional investors, financial advisors, and individuals. Known for its research-driven approach, AB offers a diverse range of investment strategies, including equities, fixed income, alternatives, and multi-asset solutions, with a strong emphasis on active management and ESG (environmental, social, governance) integration. The firm, which relocated its headquarters from New York City to Nashville in 2021, operates globally with significant operations in New York, London, and Asia, leveraging its Bernstein Research arm for deep market insights. With a workforce of over 4,700 and a partnership structure led by CEO Seth Bernstein, AB combines a legacy of rigorous analysis with a modern focus on sustainable investing and client outcomes.
Top Buys
| 1 |
Stellantis
STLA
|
+$778M |
| 2 |
Adobe
ADBE
|
+$760M |
| 3 |
Amazon
AMZN
|
+$507M |
| 4 |
American Express
AXP
|
+$324M |
| 5 |
Meta Platforms (Facebook)
META
|
+$287M |
Top Sells
| 1 |
Alphabet (Google) Class C
GOOG
|
+$439M |
| 2 |
Electronic Arts
EA
|
+$392M |
| 3 |
International Flavors & Fragrances
IFF
|
+$357M |
| 4 |
Johnson & Johnson
JNJ
|
+$303M |
| 5 |
TJX Companies
TJX
|
+$293M |
Sector Composition
| 1 | Technology | 22.86% |
| 2 | Healthcare | 15.27% |
| 3 | Consumer Discretionary | 13.02% |
| 4 | Financials | 12.77% |
| 5 | Industrials | 9.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2601
Gates Industrial
GTES
$6.52B
| $564K | ﹤0.01% |
35,257
+3,300
| +10% | +$52.8K |
|
|
PETQ
2602
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
| $564K | ﹤0.01% |
16,000
-3,000
| -16% | -$106K |
|
2603
Cass Information Systems
CASS
$562M
| $563K | ﹤0.01% |
12,166
-4,200
| -26% | -$194K |
|
|
GAN
2604
DELISTED
GAN Ltd
GAN
| $562K | ﹤0.01% |
+30,900
| New | +$562K |
|
2605
The Joint Corp
JYNT
$157M
| $561K | ﹤0.01% |
11,600
-3,200
| -22% | -$155K |
|
|
ICPT
2606
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $560K | ﹤0.01% |
24,270
-11,700
| -33% | -$270K |
|
|
CLIM
2607
DELISTED
Climate Real Impact Solutions II Acquisition Corporation
CLIM
| $560K | ﹤0.01% |
+57,556
| New | +$560K |
|
|
CLDT
2608
Chatham Lodging
CLDT
$349M
| $559K | ﹤0.01% |
42,472
-18,130
| -30% | -$239K |
|
2609
Precigen
PGEN
$1.23B
| $553K | ﹤0.01% |
80,300
-13,300
| -14% | -$91.6K |
|
2610
Relmada Therapeutics
RLMD
$53.4M
| $553K | ﹤0.01% |
15,700
| – | – |
|
2611
Acco Brands
ACCO
$357M
| $544K | ﹤0.01% |
64,505
-43,603
| -40% | -$368K |
|
|
ATRS
2612
DELISTED
Antares Pharma, Inc.
ATRS
| $544K | ﹤0.01% |
132,300
-18,100
| -12% | -$74.4K |
|
|
AC
2613
DELISTED
Associated Capital Group
AC
| $542K | ﹤0.01% |
15,103
-1,900
| -11% | -$68.2K |
|
2614
MBIA
MBI
$374M
| $538K | ﹤0.01% |
55,900
-27,200
| -33% | -$262K |
|
2615
Minerva Neurosciences
NERV
$15M
| $538K | ﹤0.01% |
23,038
-1,275
| -5% | -$29.8K |
|
2616
Immunovant
IMVT
$2.93B
| $537K | ﹤0.01% |
33,500
-43,937
| -57% | -$704K |
|
|
TPCO
2617
DELISTED
Tribune Publishing Company Common Stock
TPCO
| $536K | ﹤0.01% |
29,800
-2,800
| -9% | -$50.4K |
|
|
GSAQ
2618
DELISTED
Global Synergy Acquisition Corp. Class A Ordinary Shares
GSAQ
| $535K | ﹤0.01% |
+55,175
| New | +$535K |
|
2619
Koppers
KOP
$543M
| $534K | ﹤0.01% |
15,363
-9,565
| -38% | -$332K |
|
2620
C3.ai
AI
$2.26B
| $532K | ﹤0.01% |
8,075
-315,919
| -98% | -$20.8M |
|
2621
Hyster-Yale Materials Handling
HY
$637M
| $531K | ﹤0.01% |
6,098
+167
| +3% | +$14.5K |
|
2622
Pulmonx
LUNG
$65.6M
| $531K | ﹤0.01% |
11,600
+2,400
| +26% | +$110K |
|
2623
DHT Holdings
DHT
$1.99B
| $527K | ﹤0.01% |
88,800
-30,000
| -25% | -$178K |
|
|
POW
2624
DELISTED
Powered Brands Class A Ordinary Shares
POW
| $526K | ﹤0.01% |
+54,075
| New | +$526K |
|
2625
Resources Connection
RGP
$167M
| $521K | ﹤0.01% |
38,461
-6,863
| -15% | -$93K |
|